Expanded terminal sedation in end-of-life care

Despite advances in palliative care, some patients still suffer significantly at the end of life. Terminal Sedation (TS) refers to the use of sedatives in dying patients until the point of death. The following limits are commonly applied: (1) symptoms should be refractory, (2) sedatives should be ad...

Full description

Saved in:  
Bibliographic Details
Authors: Gilbertson, Laura (Author) ; Savulescu, Julian 1963- (Author) ; Oakley, Justin (Author) ; Wilkinson, Dominic (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Interlibrary Loan:Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany)
Published: 2023
In: Journal of medical ethics
Year: 2023, Volume: 49, Issue: 4, Pages: 252-260
Online Access: Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002c 4500
001 1918661413
003 DE-627
005 20250227050343.0
007 cr uuu---uuuuu
008 250226s2023 xx |||||o 00| ||eng c
024 7 |a 10.1136/jme-2022-108511  |2 doi 
035 |a (DE-627)1918661413 
035 |a (DE-599)KXP1918661413 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Gilbertson, Laura  |e VerfasserIn  |4 aut 
245 1 0 |a Expanded terminal sedation in end-of-life care 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Despite advances in palliative care, some patients still suffer significantly at the end of life. Terminal Sedation (TS) refers to the use of sedatives in dying patients until the point of death. The following limits are commonly applied: (1) symptoms should be refractory, (2) sedatives should be administered proportionally to symptoms and (3) the patient should be imminently dying. The term ‘Expanded TS’ (ETS) can be used to describe the use of sedation at the end of life outside one or more of these limits. In this paper, we explore and defend ETS, focusing on jurisdictions where assisted dying is lawful. We argue that ETS is morally permissible: (1) in cases of non-refractory suffering where earlier treatments are likely to fail, (2) where gradual sedation is likely to be ineffective or where unconsciousness is a clinically desirable outcome, (3) where the patient meets all criteria for assisted dying or (4) where the patient has greater than 2 weeks to live, is suffering intolerably, and sedation is considered to be the next best treatment option for their suffering. While remaining two distinct practices, there is scope for some convergence between the criteria for assisted dying and the criteria for ETS. Dying patients who are currently ineligible for TS, or even assisted dying, should not be left to suffer. ETS provides one means to bridge this gap. 
700 1 |e VerfasserIn  |0 (DE-588)1163621471  |0 (DE-627)102793496X  |0 (DE-576)508091942  |4 aut  |a Savulescu, Julian  |d 1963- 
700 1 |a Oakley, Justin  |e VerfasserIn  |4 aut 
700 1 |e VerfasserIn  |0 (DE-588)1035485133  |0 (DE-627)747586047  |0 (DE-576)383073898  |4 aut  |a Wilkinson, Dominic 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 49(2023), 4, Seite 252-260  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnas 
773 1 8 |g volume:49  |g year:2023  |g number:4  |g pages:252-260 
856 |u https://jme.bmj.com/content/medethics/early/2022/12/21/jme-2022-108511.full.pdf  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [deprecated] 
856 4 0 |u https://doi.org/10.1136/jme-2022-108511  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://jme.bmj.com/content/49/4/252  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4673504909 
LOK |0 003 DE-627 
LOK |0 004 1918661413 
LOK |0 005 20250226164221 
LOK |0 008 250226||||||||||||||||ger||||||| 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixzo  |a ixrk 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw